Re‐evaluating prognostic indicators: The critical role of body composition and gene expression in endometrial cancer outcomes
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.70016 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Mauricio A Cuello und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, School of Medicine, Pontificia Universidad Católica de Chile (PUC), Santiago, Chile. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Body Composition, Gene Expression. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Fondecyt, FONDAP, CONICYT.
Abstract (Originalsprache)
Objective
To investigate the impact of body mass index (BMI), body composition (BC), and the expression of genes linked to obesity or lipid metabolism on the prognosis of endometrial cancer.
Methods
We conducted a comprehensive review of patients with confirmed endometrial cancer treated at the Pontificia Universidad Católica de Chile (PUC) and analyzed publicly available data from the endometrial cancer TCGA‐UCEC cohort. BC was assessed using computed tomography (CT) scans, and gene expression analysis was performed using RNA‐seq data. We evaluated the associations between BMI, BC, gene expression, and patient outcomes, including overall survival (OS) and progression‐free survival (PFS).
Results
Our study included 127 patients (67 from PUC and 60 from TCGA‐UCEC). BMI was not significantly associated with OS or PFS. However, BC metrics such as visceral adiposity and muscle mass were critical determinants of prognosis. We identified a 30‐gene risk score significantly associated with poorer PFS and OS, independent of other factors. Analysis of the tumor microenvironment (TME) revealed significant differences in immune cell composition and functional states between high‐ and low‐risk groups.
Conclusion
BMI alone is not a significant prognostic factor in endometrial cancer. Comprehensive assessments of BC, gene expression profiles, and the TME provide more accurate prognostic information and highlight potential therapeutic targets. These findings advocate for a shift towards personalized medicine, incorporating detailed phenotyping and molecular profiling to improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, School of Medicine, Pontificia Universidad Católica de Chile (PUC), Santiago, Chile.
- Gynecologic Oncology Unit, Hospital Clínico Universidad Católica, UC-Christus Health Network, Santiago, Chile.
- Center for Cancer Prevention and Control (CECAN), Santiago, Chile.
- Advanced Center for Chronic Diseases (ACCDiS), Santiago, Chile.
- Precision Oncology Center, School of Medicine, Universidad Mayor, Santiago, Chile.
- Department of Obstetrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
ORCID-Profile: Mauricio A Cuello
Förderung
- Fondecyt
- FONDAP
- CONICYT
- Fondo Nacional de Desarrollo Científico y Tecnológico
- Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias
- Consejo Nacional de Innovación, Ciencia y Tecnología
Zitieren
APA
Cuello, M. A., Gómez-Valenzuela, F., Ossandón, E., Wichmann, I., Orlandini, E., Sáez, N., Brañes, J., Kato, S., & Ibañez, C. (2025). Re‐evaluating prognostic indicators: The critical role of body composition and gene expression in endometrial cancer outcomes. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70016
Vancouver
Cuello MA, Gómez-Valenzuela F, Ossandón E, Wichmann I, Orlandini E, Sáez N, et al. Re‐evaluating prognostic indicators: The critical role of body composition and gene expression in endometrial cancer outcomes. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70016
BibTeX
@article{Cuello2025,
author = {Cuello, Mauricio A and Gómez-Valenzuela, Fernán and Ossandón, Enrique and Wichmann, Ignacio and Orlandini, Elisa and Sáez, Nicolás and Brañes, Jorge and Kato, Sumie and Ibañez, Carolina},
title = {Re‐evaluating prognostic indicators: The critical role of body composition and gene expression in endometrial cancer outcomes},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.70016}
}
EUVIMED